GPR137B Inhibitors

GPR137B inhibitors, by their nature, encompass a diverse range of molecules that are designed to modulate the function and activity of the G protein-coupled receptor 137B. Pertussis toxin, for instance, is a notable inhibitor that targets the Gi/Go family of G proteins, crucial components of the GPCR signaling machinery. By influencing these G proteins, the downstream signaling cascade that GPR137B might be involved in can be affected. On a similar note, Cholera toxin targets the Gs protein, which plays a significant role in cAMP modulation, a frequent outcome of GPCR activation. Another dimension of GPCR modulation arises from compounds like Propranolol and Clozapine. These compounds, while not directly targeting GPR137B, interact with various GPCRs, providing an indirect influence on the broader GPCR signaling milieu. Additionally, specific molecular modulators like YM-254890 and U73122 target integral components of the GPCR signaling cascade, namely the Gq/11 family of G proteins and Phospholipase C respectively. Other compounds like ML141 and SecinH3 delve deeper into GPCR dynamics by targeting GTPases and factors involved in receptor internalization, respectively.